SciELO - Scientific Electronic Library Online

 
vol.19 issue4Replacing procarbazine with etoposide in a new OEPA/COPE treatment scheme in children and adolescents with Hodgkin lymphoma: An evaluation of outcomes in the National Cancer InstituteSpinal cord compression due to nonleukemic granulocytic sarcoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cancerología

Print version ISSN 0123-9015

Abstract

ARDILA-MOLANO, Javier; VIZCAINO, Milena  and  SERRANO, Martha Lucía. Circulating microRNAs as potential cancer biomarkers. rev.colomb.cancerol. [online]. 2015, vol.19, n.4, pp.229-238. ISSN 0123-9015.  http://dx.doi.org/10.1016/j.rccan.2015.08.002.

Cancer is currently recognized as a major cause of mortality worldwide, and, as such, has a significant impact on public health. Successful early detection strategies are linked to a decrease in mortality; however, because they are invasive, highly complex, and have low specificity, their application has been limited. MicroRNAs (miRNAs) are short, non-coding RNA sequences capable of regulating gene expression. Molecular mechanisms of miRNAs in cancer are not fully understood, but specific patterns of miRNAs expression have been associated with many tumour types. MicroRNAs as biomarkers can help to identify tumour origin and allow their early detection. They can also be used to monitor progression and therapeutic response. The presence and stability of miRNAs in blood, as circulating miRNAs, are major factors that contribute to their use as potential biomarkers in a clinical context. The aim of this article is to present a review of miRNAs as circulating biomarkers in cancer.

Keywords : Circulating microRNA; Early detection; Cancer; Biomarkers; Prognosis.

        · abstract in Spanish     · text in English     · English ( pdf )